September 4, 2012
Monitoring and understanding a patient's response to therapy plays a central role in optimizing cancer treatment. Advanced imaging technologies could enable monitoring of tumor response at an earlier stage in the treatment course, providing a means for personalized therapy adaptation.
At the American Association of Physicists in Medicine (AAPM) annual meeting in Charlotte, NC, "Imaging for Therapy Assessment" was the theme of the John S. Laughlin Science Council Research Symposium. Each year, this symposium addresses a chosen topic of particular relevance in medical physics research, this time highlighting the need to develop sensitive and specific quantitative imaging techniques as surrogate biomarkers for use in clinical trials and routine clinical practice.